No adverse reactions were reported in either group.<h4>Conclusion</h4>The combination of HXTQD and aniracetam can significantly improve cognitive function and cerebral perfusion in elderly patients with post-ischemic stroke cognitive impairment, potentially by regulating serum SOD, GSH-Px and NO levels. The gene discussed is SOD1; the disease is Cognitive impairment.